Glucon Inc., a Boulder, Colo.-based developer of an automated blood glucose measurement system for hospitalized patients, has raised an undisclosed amount of Series D funding. 3i Group led the deal, and was joined by Sequel Venture Partners, Quest Capital Partnership, Hunt Ventures and return backers Aurum Ventures, Giza Venture Capital, MKI, Infinity Venture Capital Fund and Ascend Technology Ventures. < ?xml:namespace prefix = o ns = "urn:schemas-microsoft-com:office:office" />